ArticleJournal of gastric cancer2019

Choice of Capecitabine or S1 in Combination with Oxaliplatin based on Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase Expression Status in Patients with Advanced Gastric Cancer.

Rong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.